# ACAMPROSATE CALCIUM
> **ANDA202229** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2013-07-16
## Drug
- **FDA Application Number:** ANDA202229
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACAMPROSATE CALCIUM
- **Generic name:** ACAMPROSATE CALCIUM
- **Active ingredients:** ACAMPROSATE CALCIUM
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS LTD
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2013-07-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202229)
---
*MORVS · CC0 1.0*